Supernus Pharmaceuticals (SUPN) News Today $32.96 +0.63 (+1.95%) Closing price 04:00 PM EasternExtended Trading$32.93 -0.03 (-0.10%) As of 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SUPN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Supernus Pharma to Buy Sage Therapeutics for Up to $795 MillionJune 17 at 12:40 AM | marketwatch.comSupernus enters depression drug market with up to $795 million Sage dealJune 17 at 12:40 AM | msn.comSupernus to acquire depression drugmaker SageJune 17 at 12:40 AM | msn.comSupernus Pharmaceuticals Gets Retail Excited Over $795M Acquisition Plan For Sage TherapeuticsJune 17 at 12:40 AM | msn.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.June 16 at 5:31 PM | prnewswire.comSupernus Pharmaceuticals (SUPN) to Acquire Sage Therapeutics in $795M DealJune 16 at 8:52 AM | gurufocus.comSupernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry ...June 16 at 8:52 AM | gurufocus.comSupernus Pharmaceuticals to Acquire Sage Therapeutics in a Strategic Move | SUPN stock newsJune 16 at 8:51 AM | gurufocus.comSage Therapeutics Stock Soars 35% After Sale to Supernus Pharmaceuticals. What We Know.June 16 at 8:26 AM | barrons.comSupernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry ...June 16 at 7:56 AM | gurufocus.comSupernus Pharma to acquire Sage Therapeutics in up to $795 million dealJune 16 at 7:14 AM | reuters.comSupernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product PortfolioJune 16 at 7:00 AM | globenewswire.comAzzad Asset Management Inc. ADV Acquires New Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Azzad Asset Management Inc. ADV acquired a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,847 shares of the specialty phaJune 16 at 4:15 AM | marketbeat.comGAMMA Investing LLC Grows Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)GAMMA Investing LLC raised its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 4,005.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,230 shares of the specialty pharmaceutical companyJune 16 at 3:02 AM | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) and Nabriva Therapeutics (NASDAQ:NBRV) Financial SurveyJune 14, 2025 | americanbankingnews.comWedge Capital Management L L P NC Acquires 13,955 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Wedge Capital Management L L P NC boosted its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 26.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 67,286 shares of the specialty pharmJune 10, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Two Sigma Investments LPTwo Sigma Investments LP lowered its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 70.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,987 shares of the specialty pharmaceutiJune 7, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Acquires 11,304 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Hennion & Walsh Asset Management Inc. raised its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 17.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 77,610 shares of the specialty pJune 5, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.62 Million Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 24.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fuJune 5, 2025 | marketbeat.comMillennium Management LLC Trims Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Millennium Management LLC lowered its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 87.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 30,470 shares of the specialty pharmaceuticaJune 5, 2025 | marketbeat.comBranded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE)June 2, 2025 | msn.comJefferies Financial Group Inc. Buys Shares of 24,600 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Jefferies Financial Group Inc. bought a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 24,600 shares of theMay 31, 2025 | marketbeat.comVoloridge Investment Management LLC Cuts Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Voloridge Investment Management LLC reduced its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 85.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,497 shares of thMay 31, 2025 | marketbeat.comJay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus PharmaceuticalsMay 29, 2025 | globenewswire.comSupernus to Participate in the 2025 Jefferies Global Healthcare ConferenceMay 28, 2025 | globenewswire.comSupernus Announces Paragraph IV ANDA Filings for Qelbree®May 28, 2025 | globenewswire.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT), 908 Devices (MASS) and Supernus Pharmaceuticals (SUPN)May 24, 2025 | theglobeandmail.comWoodline Partners LP Raises Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Woodline Partners LP boosted its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 124.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 423,828 shares of the specialty pharmaceutMay 24, 2025 | marketbeat.comPoint72 Asset Management L.P. Buys Shares of 26,828 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Point72 Asset Management L.P. purchased a new position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 26,828 shares of the specialtyMay 24, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by Deutsche Bank AGDeutsche Bank AG grew its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 226.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 105,583 shares of the specialty pharmaceutical company'sMay 22, 2025 | marketbeat.comSupernus Pharmaceuticals Partners with Busy Philipps for "Ms. Represented" Campaign to Empower Women with ADHDMay 20, 2025 | quiverquant.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Acquired by Systematic Financial Management LPSystematic Financial Management LP raised its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 302.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1May 20, 2025 | marketbeat.comCaptrust Financial Advisors Boosts Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Captrust Financial Advisors raised its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 84.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,394 sMay 20, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Ameriprise Financial Inc.Ameriprise Financial Inc. trimmed its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 17.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 450,261 shares of the specialty pharmaceuticaMay 19, 2025 | marketbeat.comJefferies Financial Group Inc. Buys New Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Jefferies Financial Group Inc. bought a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 24,600 sharesMay 18, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Polar Capital Holdings PlcPolar Capital Holdings Plc decreased its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 12.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,687,930 sharesMay 17, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Has $19.73 Million Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)D. E. Shaw & Co. Inc. raised its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 33.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 545,658 shares of the specialty pharmMay 15, 2025 | marketbeat.comDZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Sells 103,501 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main cut its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 72.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The instMay 14, 2025 | marketbeat.comCentiva Capital LP Acquires New Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Centiva Capital LP acquired a new stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 9,151 shares of the specialty pharmaceutical company's stock, valued atMay 14, 2025 | marketbeat.comBNP Paribas Financial Markets Buys 208,552 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)BNP Paribas Financial Markets boosted its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 248.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 292,629 shares of theMay 14, 2025 | marketbeat.comSolid Earnings Reflect Supernus Pharmaceuticals' (NASDAQ:SUPN) Strength As A BusinessMay 13, 2025 | finance.yahoo.comComerica Bank Buys 15,585 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Comerica Bank increased its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 71.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 37,548 shares of the specialty pharmaceutical company's stock after purchasing an additional 1May 13, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Invests $388,000 in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Schonfeld Strategic Advisors LLC bought a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 10,730 shares of the specialty pharmaceutical compMay 13, 2025 | marketbeat.comNorthern Trust Corp Increases Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Northern Trust Corp boosted its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 18.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 717,161 shares of the specialty pharmaceutical compMay 13, 2025 | marketbeat.comCubist Systematic Strategies LLC Increases Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)Cubist Systematic Strategies LLC raised its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 944.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 139,522 sharesMay 11, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by First Trust Advisors LPFirst Trust Advisors LP lowered its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 48.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,019 sharMay 10, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc.: Supernus Announces First Quarter 2025 Financial ResultsMay 10, 2025 | finanznachrichten.deSupernus Pharmaceuticals (SUPN) to Release Quarterly Earnings on WednesdaySupernus Pharmaceuticals (NASDAQ:SUPN) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 14. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-14-supernus-pharmaceuticals-inc-stock/)May 9, 2025 | marketbeat.comSupernus Pharmaceuticals Reports 44% Increase in Qelbree® Sales and Launches ONAPGO™ in Q1 2025May 9, 2025 | nasdaq.comSupernus Pharmaceuticals Inc (SUPN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...May 7, 2025 | gurufocus.com Get Supernus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter. Email Address SUPN Media Mentions By Week SUPN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SUPN News Sentiment▼0.310.56▲Average Medical News Sentiment SUPN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SUPN Articles This Week▼156▲SUPN Articles Average Week Get Supernus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies JAZZ News PRGO News PCRX News OMER News ASMB News NKTR News CPIX News LLY News JNJ News ABBV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SUPN) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
